Patents Assigned to ENDODERMA CO., LTD.
  • Patent number: 11285308
    Abstract: The present invention relates to a microstructure including a biocompatible polymer or an adhesive and to a method for manufacturing the same. The present inventors optimized the aspect ratio according to the type of each microstructure, thereby ensuring the optimal tip angle and the diameter range for skin penetration. Especially, the B-type to D-type microstructures of the present invention minimize the penetration resistance due to skin elasticity at the time of skin attachment, thereby increasing the penetration rate of the structures (60% or higher) and the absorption rate of useful ingredients into the skin. In addition, the D-type microstructure of the present invention maximizes the mechanical strength of the structure by applying a triple structure, and thus can easily penetrate the skin. When the plurality of microstructures are arranged in a hexagonal arrangement type, a uniform pressure can be transmitted to the whole microstructures on the skin.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: March 29, 2022
    Assignee: ENDODERMA CO., LTD.
    Inventors: Jae Soo Kim, Soon Chang Kwon, Sang Jin Park
  • Patent number: 11013670
    Abstract: The present invention relates to a hyaluronic acid microstructure having excellent solubility characteristics. More specifically, the present invention relates to a biodegradable microstructure comprising crosslinked hyaluronic acid and having excellent solubility characteristics during skin penetration. When the microstructure of the present invention is penetrated into the skin, the solubility characteristics in the skin are excellent, the dissolution rate in the skin can be easily controlled according to the content ratio of the crosslinked hyaluronic acid, and, while effective ingredients provided on the microstructure can be stably delivered into the skin, the release rate of the provided effective ingredients can be easily controlled, and thus the present invention can be used as a transdermal delivery system for pharmacologically active materials or skin improvement materials.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: May 25, 2021
    Assignee: ENDODERMA CO., LTD.
    Inventors: Jae Soo Kim, Soon Chang Kwon, Sang Jin Park
  • Patent number: 10493160
    Abstract: The present invention provides microstructures using crosslinked hyaluronic acid hydrogels and the method for preparing the same. The present invention for preparing microstructures using crosslinked hyaluronic acid hydrogels allows the preparation of microstructures with a uniform shape and minimum deformation. Furthermore, the microstructures made using crosslinked hyaluronic acid hydrogels in the present invention can improve skin aging, e.g. wrinkles, replenish moisture, easily absorb body fluids due to its outstanding swelling performance, provide a longer duration in the body due to its resistance against a hyaluronic acid hydrolyzing enzyme, enabling the safe delivery of effective components in the body.
    Type: Grant
    Filed: February 15, 2016
    Date of Patent: December 3, 2019
    Assignee: ENDODERMA CO., LTD.
    Inventors: Jae Soo Kim, Soon Chang Kwon, Sang Jin Park
  • Publication number: 20190336411
    Abstract: The present invention relates to a hyaluronic acid microstructure having excellent solubility characteristics. More specifically, the present invention relates to a biodegradable microstructure comprising crosslinked hyaluronic acid and having excellent solubility characteristics during skin penetration. When the microstructure of the present invention is penetrated into the skin, the solubility characteristics in the skin are excellent, the dissolution rate in the skin can be easily controlled according to the content ratio of the crosslinked hyaluronic acid, and, while effective ingredients provided on the microstructure can be stably delivered into the skin, the release rate of the provided effective ingredients can be easily controlled, and thus the present invention can be used as a transdermal delivery system for pharmacologically active materials or skin improvement materials.
    Type: Application
    Filed: June 16, 2017
    Publication date: November 7, 2019
    Applicant: ENDODERMA CO., LTD.
    Inventors: Jae Soo KIM, Soon Chang KWON, Sang Jin PARK